BPA
LABU icon

Beacon Pointe Advisors’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Beacon Pointe Advisors’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,550
Closed -$219K – 1182
2022
Q4 		$219K Hold
1,550
– – ﹤0.01% 966
2022
Q3 		$217K Buy
1,550
+200
+15% +$36.7K ﹤0.01% 902
2022
Q2 		$181K Buy
+1,350
New +$230K ﹤0.01% 976

Other funds holding LABU

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $7.5B AUM 33.9% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
IMC Chicago
IMC Chicago Chicago, Illinois $278B AUM 44.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AIP
Ahrens Investment Partners Lafayette, Louisiana $202M AUM 3.91% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Beacon Pointe Advisors's LABU Position: Q1 2023 in Review

Beacon Pointe Advisors sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q1 2023, closing a stake of 1,550 shares — an estimated $219K sold.

Beacon Pointe Advisors first reported a position in LABU in Q2 2022 and held it in 3 quarters. The position peaked at $219K in Q4 2022. 57 funds tracked by Wall St. Rank hold LABU as of Q1 2023.

  • Beacon Pointe Advisors reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q1 2023 after selling out during the quarter.
  • Beacon Pointe Advisors sold 1,550 Direxion Daily S&P Biotech Bull 3X ETF shares in Q1 2023, an estimated $219K.
  • Beacon Pointe Advisors first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q2 2022 and held it in 3 quarters.
  • Beacon Pointe Advisors's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $219K in Q4 2022.
  • 57 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q1 2023.

Based on Beacon Pointe Advisors's 13F filing for Q1 2023, filed 12 May 2023.